The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models

CNU IR > Pharmacy and Science > Dept. of Biotechnology (including master's program) > Periodical Articles > Item 310902800/34602

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34602

题名:	The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models
作者:	Lin, Ching-Yen Chen, Pei-Yi Hsu, Hao-Jen Gao, Wan-Yun Wu, Ming-Jiuan Yen, Jui-Hung
贡献者:	Tzu Chi University Buddhist Tzu Chi General Hospital Tzu Chi University Tzu Chi University Department of Biotechnology, Chia Nan University of Pharmacy & Science
关键词:	high-density-lipoprotein cardiovascular-disease selective uptake metabolism cholesterol lipase gene triglycerides suppresses kinase
日期:	2022
上传时间:	2023-12-11 14:00:06 (UTC+8)
出版者:	MDPI
摘要:	Nobiletin, a dietary citrus flavonoid, exerts biological activities against hyperlipidemia, obesity, and atherosclerotic cardiovascular diseases (ASCVDs). The aim of this study was to explore the lipid-lowering effects of nobiletin and the underlying molecular mechanisms in vitro in hepatic cells and in vivo in zebrafish models. Transcriptome and gene ontology (GO) analyses of differentially expressed genes (DEGs) by gene set enrichment analysis (GSEA) showed that a set of twenty-eight core enrichment DEGs associated with GO BP regulation of lipid metabolic process (GO: 0019216) were significantly downregulated in nobiletin-treated cells. Among these genes, angiopoietin-like 3 (ANGPTL3), an inhibitor of lipoprotein lipase (LPL) activity that regulates TG-rich lipoprotein (TGRL) metabolism in circulation, was the protein most markedly downregulated by nobiletin. Nobiletin (20 and 40 mu M) significantly reduced the levels of ANGPTL3 mRNA and intracellular and secreted ANGPTL3 proteins in hepatic cell lines. Furthermore, alleviation of secreted ANGPTL3 production by nobiletin was found to reinstate LPL catalytic activity. Nobiletin significantly inhibited ANGPTL3 promoter activity and attenuated the transcription factor liver X receptor-alpha (LXR alpha)-mediated ANGPTL3 transcription. Molecular docking analysis predicted that nobiletin could bind to the ligand-binding domain of LXR alpha, thereby counteracting LXR alpha activation. In animal studies, orally administered nobiletin significantly alleviated the levels of plasma triglycerides (TGs) and cholesterol in zebrafish fed a high-fat diet. Moreover, nobiletin significantly reduced the amounts of hepatic ANGPTL3 protein in zebrafish. Our findings suggest that nobiletin may regulate the LXR alpha-ANGPTL3-LPL axis and exhibit lipid-modulating effects in vitro and in vivo. Thus, nobiletin is a potential ANGPTL3 inhibitor for the regulation of lipid metabolism to ameliorate dyslipidemia and ASCVDs.
關聯:	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.23, n.20, 12485
显示于类别:	[Dept. of Biotechnology (including master's program)] Periodical Articles

文件中的档案:

档案	描述	大小	格式	浏览次数
ijms-23-12485.pdf		5021Kb	Adobe PDF	299	检视/开启
index.html		0Kb	HTML	533	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....